CHICAGO, Aug. 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanzaâ„¢ to treat community acquired bacterial pneumonia (CABP).
Vaccine Reduces Pneumonia and Complications in Infants, Study Says
PHILADELPHIA, July 19 /PRNewswire-USNewswire/ -- A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.
Natural Pneumonia Treatment - Part 1
Pneumonia is a serious infection of the lungs that can be caused by any of a number of different infectious agents, including viruses, bacteria, fungi, protozoa, and mycoplasma The infection causes tiny air sacs in the lung area to become inflamed and filled with mucus and pus, inhibiting oxygen from reaching the blood
